Ann: FDA Orphan Drug Designation for AD-214, page-16

Yup trial results showing positive signs with results incoming March and April. Part B results also coming probably by February 2022. So looks like an easy investing opportunity that I could not miss out on. March and April results will probably be really good, so it’s a easy hold for me until Part B results next year. Expecting 100 million MC to be reached this year and after part B results who knows what kind of valuation we can expect. It’s a 1 year hold for me and I am happy with a 30% profit in a years time so not that worried about daily fluctuations. Just ride out a year and the trial results and see where my investment is at next February . Simple Observations shows we have achieved a new high at 26c so considering the upcoming pipeline for the year...should be some easy profits when it retraces back to 26c atleast. 40Mill market... lots of opportunities for growth...just going to hold this one for a year and see where we are at next February